CELZ Stock Analysis: Buy, Sell, or Hold?
CELZ - Creative Medical Technology Holdings, Inc. Common Stock
$1.99
0.02 (0.76%)
▲
5d:
-11.38%
30d:
-16.95%
90d:
+9.67%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: May 08, 2026
0d
Get Alerted When CELZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CELZ shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CELZ shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CELZ is currently trading at $1.99, which is considered oversold relative to its 30-day fair value range of $2.08 to $2.31.
Technical Outlook: Technically, CELZ is in a strong uptrend. Immediate support is located at $1.92, while resistance sits at $2.49.
Market Sentiment: CELZ has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $20.00 (+915.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CELZ is in a strong uptrend. Immediate support is located at $1.92, while resistance sits at $2.49.
Market Sentiment: CELZ has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $20.00 (+915.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.08 -
$2.31
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 915.2% below Wall St target ($20.00)
- CAUTION: 5-day price weakness (-11.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.08 -
$2.31
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.92
Resistance Level
$2.49
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.30
Wall Street Target
$20.00
(+915.2%)
Earnings Growth (YoY)
358.9%
Share & Embed Analysis
Last updated: June 24, 2026 11:38 AM ET
Data refreshes hourly during market hours. Next update: 12:38 PM
Data refreshes hourly during market hours. Next update: 12:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELZ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 57 HOLD |
